Drug intelligence / Profile preview

mesohyal argibenone

Development stage
Unknown
Lead developer
Mesoestetic
Modality
Peptides, Small Molecules
Administration
Intradermal
01

Overview

Mesohyal argibenone is a professional anti-aging and antioxidant intradermal injectable solution, developed by Mesoestetic, combining non-crosslinked hyaluronic acid (15 mg/ml), acetyl hexapeptide-8 (a biomimetic peptide also known as argireline), and idebenone (a potent antioxidant akin to coenzyme Q10)[1][2][4][5][7]. The preparation acts by hydrating and plumping skin (hyaluronic acid), reducing dynamic facial wrinkles through the reversible inhibition of acetylcholine exocytosis (acetyl hexapeptide-8, which acts similarly to botulinum toxin by blocking neuromuscular transmission), and protecting cells/DNA against oxidative stress and photoaging (idebenone protects against lipid/protein oxidation and supports mitochondrial function)[1][2][4]. Indicated for facial rejuvenation, wrinkle reduction, photoaging, and improving skin firmness primarily on the face, neck, and décolletage, it is for professional use only via intradermal injection. Typical regimens involve five sessions at 15-day intervals, with effects lasting up to 9 months[1].

Brand names
mesohyal argibenone
Other names
mesohyal argibenonemesohyal argibenone 5x3mlmesoestetic mesohyal argibenone
02

Targets

SNAP25 (Synaptosome-associated protein 25)

Beyond the preview

Go deeper on mesohyal argibenone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mesohyal argibenone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call